Finance

Lists
000623:SHE
Jilin Aodong Pharmaceutical Group Co Ltd
CN¥17,40
-0,57%
(-0,10) 1D
13 Okt., 15:04:54 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000623...
Open
CN¥17,40
High
CN¥17,50
Low
CN¥17,24
Mkt. cap
20,93 mjd
Avg. vol.
9,76 m
Volume
6,84 m
P/E ratio
6,45
52-wk high
CN¥22,08
52-wk low
CN¥16,36
EPS
CN¥2,70
Shares outstanding
1,20 mjd
No. of employees
5 k
Open
CN¥17,40
High
CN¥17,50
Low
CN¥17,24
Mkt. cap
20,93 mjd
Avg. vol.
9,76 m
Volume
6,84 m
P/E ratio
6,45
52-wk high
CN¥22,08
52-wk low
CN¥16,36
EPS
CN¥2,70
Shares outstanding
1,20 mjd
No. of employees
5 k
News stories
From web sources and news partners
Profile
Jilin Aodong Medicine Industry Group Company Limited is a state-owned enterprise in Dunhua, Jilin, China. It involves in the manufacture and sale of Chinese patent drugs and pharmaceutical packaging products, and the collection of traffic tolls and the road engineering construction business. It was established in 1993 and listed on the Shenzhen Stock Exchange in 1996. Wikipedia
About Jilin Aodong Pharmaceutical Group Co Ltd
CEO-
Employees5,05 k
Founded20 Mrt. 1993
Headquarters-
SectorPharmaceutical industry
Websitejlaod.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
513,94 m
694,88 m
514,09 m
516,91 m
Cost of goods sold
277,23 m
401,66 m
265,19 m
285,23 m
Cost of revenue
277,23 m
401,66 m
265,19 m
285,23 m
Research and development expenses
20,32 m
50,31 m
14,36 m
14,41 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
217,18 m
375,32 m
194,13 m
204,97 m
Operating expense
213,20 m
462,78 m
225,97 m
230,21 m
Total operating expenses
490,43 m
864,44 m
491,16 m
515,45 m
Operating income
23,51 m
-169,57 m
22,94 m
1,46 m
Other non operating income
8,50 m
-11,31 m
-653,65 k
1,59 m
EBT including unusual items
1,02 mjd
76,89 m
865,54 m
1,14 mjd
EBT excluding unusual items
881,21 m
310,73 m
905,90 m
1,31 mjd
Income tax expense
46,89 m
-29,05 m
446,06 k
-39,10 m
Effective tax rate
4,58%
-37,77%
0,05%
-3,42%
Other operating expenses
-17,06 m
38,39 m
10,48 m
10,49 m
Net income
978,96 m
134,74 m
866,00 m
1,18 mjd
Net profit margin
190,48%
19,39%
168,45%
229,06%
Earnings per share
-
-
-
-
Interest and investment income
865,41 m
507,32 m
898,86 m
1,31 mjd
Interest expense
-16,21 m
-15,71 m
-15,25 m
-6,62 m
Net interest expenses
849,20 m
491,61 m
883,61 m
1,31 mjd
Depreciation and amortization charges
-
-
-
-
EBITDA
74,98 m
-121,80 m
70,71 m
44,84 m
Gain or loss from assets sale
127,66 k
-1,32 m
-
4,80 m
AI content may include mistakes. Learn more
Google-programme